2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
117 hedge funds and large institutions have $251M invested in 2seventy bio in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 46 reducing their positions, and 15 closing their positions.
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
11% more capital invested
Capital invested by funds: $226M → $251M (+$24.5M)
1% more funds holding
Funds holding: 116 → 117 (+1)
43% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 46
44% less call options, than puts
Call options by funds: $707K | Put options by funds: $1.25M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$8.17M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.94M |
| 3 |
CC
Casdin Capital
New York
|
+$3.84M |
| 4 |
MAP
Madison Avenue Partners
New York
|
+$3.19M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$25.1M |
| 2 |
Millennium Management
New York
|
-$7.81M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$5.69M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.09M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.13M |
TSVT Hedge Fund Activity: Q1 2024 in Review
117 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q1 2024, worth a combined $251M — up 11% from $226M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TSVT positions and 15 closed out — a net gain of 3 holders — while 26 added to existing stakes and 46 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $8.17M. The largest seller was Morgan Stanley, cutting an estimated $25.1M.
- 117 institutional investors held 2seventy bio (TSVT) as of Q1 2024, up from 116 in Q4 2023.
- Funds reported $251M of 2seventy bio stock for Q1 2024, up 11% quarter-over-quarter.
- 18 funds opened new 2seventy bio positions in Q1 2024 and 15 closed out, a net change of +3 holders.
- The largest 2seventy bio buyer in Q1 2024 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $8.17M added.
- The largest 2seventy bio seller in Q1 2024 was Morgan Stanley, an estimated $25.1M sold.
Based on aggregated 13F filings for Q1 2024.